Previous close | 77.76 |
Open | 0.00 |
Bid | 64.50 x N/A |
Ask | 93.17 x N/A |
Day's range | 77.76 - 77.76 |
52-week range | 55.99 - 81.52 |
Volume | |
Avg. volume | 329 |
Market cap | 539.185B |
Beta (5Y monthly) | 0.14 |
PE ratio (TTM) | 27.00 |
EPS (TTM) | 2.88 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
In this article, we discuss the 23 most profitable stocks of the last 12 months. If you want to skip our detailed analysis of these stocks, go directly to 5 Most Profitable Stocks of the Last 12 Months. The United States stock market has come a long way since the turn of the millennium more […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $9.55 EPS, expectations were $10.17. Regeneron Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to […]
Regeneron Pharmaceuticals ( NASDAQ:REGN ) First Quarter 2024 Results Key Financial Results Revenue: US$3.15b (flat on...